325 related articles for article (PubMed ID: 19797039)
21. Two cases of acneiform eruption induced by inhibitor of epidermal growth factor receptor.
Gencoglan G; Ceylan C
Skin Pharmacol Physiol; 2007; 20(5):260-2. PubMed ID: 17641540
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy.
Micantonio T; Fargnoli MC; Ricevuto E; Ficorella C; Marchetti P; Peris K
Arch Dermatol; 2005 Sep; 141(9):1173-4. PubMed ID: 16172328
[No Abstract] [Full Text] [Related]
23. [Erlotinib-induced acneiform eruption].
Wahl RU; Megahed M
Hautarzt; 2013 May; 64(5):334-6. PubMed ID: 23535946
[TBL] [Abstract][Full Text] [Related]
24. Papulopustular acneiform eruptions resulting from trastuzumab, a HER2 inhibitor.
Sheu J; Hawryluk EB; Litsas G; Thakuria M; LeBoeuf NR
Clin Breast Cancer; 2015 Feb; 15(1):e77-81. PubMed ID: 25445421
[No Abstract] [Full Text] [Related]
25. Rosaceiform eruption induced by cetuximab.
Fernández-Torres R; Martínez Gomez W; Cuevas Santos J; Paradela S; Fonseca Capdevila E
Eur J Dermatol; 2010; 20(3):392-3. PubMed ID: 20172848
[No Abstract] [Full Text] [Related]
26. Acneiform eruptions: a common cutaneous toxicity of the MEK inhibitor trametinib.
Anforth R; Liu M; Nguyen B; Uribe P; Kefford R; Clements A; Long GV; Fernandez-Peñas P
Australas J Dermatol; 2014 Nov; 55(4):250-4. PubMed ID: 24313958
[TBL] [Abstract][Full Text] [Related]
27. [Skin eruptions as an adverse reaction to epidermal growth-factor receptor inhibitors].
Tjin-A-ton ML; van Montfrans C; Koldenhof JJ; Sigurdsson V; Voest EE; Witteveen PO
Ned Tijdschr Geneeskd; 2007 Apr; 151(17):945-52. PubMed ID: 17520845
[TBL] [Abstract][Full Text] [Related]
28. [Acneiform eruption secondary to cetuximab].
Herrera-Acosta E; Martín-Ezquerra G; Iglesias M; Umbert P
Actas Dermosifiliogr; 2005 May; 96(4):252-4. PubMed ID: 16476378
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of topical benzoyl peroxide for prolonged acneiform eruptions induced by cetuximab and panitumumab: A multicenter, phase II trial.
Tsutsui K; Kikuchi K; Nozawa K; Takashima A; Tsuchiyama K; Namikawa K; Aiba S; Yamazaki N
J Dermatol; 2021 Jul; 48(7):1077-1080. PubMed ID: 33682955
[TBL] [Abstract][Full Text] [Related]
30. Prophylactic versus reactive treatment of acneiform skin rashes from epidermal growth factor receptor inhibitors in metastatic colorectal cancer.
Dascalu B; Kennecke HF; Lim HJ; Renouf DJ; Ruan JY; Chang JT; Cheung WY
Support Care Cancer; 2016 Feb; 24(2):799-805. PubMed ID: 26184500
[TBL] [Abstract][Full Text] [Related]
31. Topical aloe vera for the treatment of cetuximab-related acneiform rash in colorectal cancer: A case report.
Gürbüz M; Akkuş E; Utkan G
J Oncol Pharm Pract; 2021 Mar; 27(2):480-484. PubMed ID: 32623964
[TBL] [Abstract][Full Text] [Related]
32. A double-blind, placebo-controlled study of the safety and efficacy of vitamin K1 ointment for the treatment of patients with cetuximab-induced acneiform eruption.
Hashimoto H; Iwasa S; Yanai T; Honma Y; Kato K; Hamaguchi T; Yamada Y; Shimada Y; Namikawa K; Tsutsumida A; Yamazaki N; Yamamoto H
Jpn J Clin Oncol; 2013 Jan; 43(1):92-4. PubMed ID: 23136238
[TBL] [Abstract][Full Text] [Related]
33. Duration of Oral Antibiotics Administration for Cetuximab-Induced Acneiform Eruption.
Park JH; Choi Y; Kim HJ; Oh SJ; Lee DY; Lee JH; Lee JH
Dermatology; 2021; 237(3):457-463. PubMed ID: 33302268
[TBL] [Abstract][Full Text] [Related]
34. Randomized, Double-Blind, Placebo-Controlled Phase Ⅱ Study on the Efficacy and Safety of Vitamin K1 Ointment for Cetuximab or Panitumumab-Induced Acneiform Eruptions-VIKTORIA Study.
Hashimoto H; Iwasa S; Yanai-Takahashi T; Honma Y; Kato K; Hamaguchi T; Yamada Y; Shimada Y; Yamazaki N; Kato Y
Gan To Kagaku Ryoho; 2020 Jun; 47(6):933-939. PubMed ID: 32541171
[TBL] [Abstract][Full Text] [Related]
35. Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients.
Gerber PA; Meller S; Eames T; Buhren BA; Schrumpf H; Hetzer S; Ehmann LM; Budach W; Bölke E; Matuschek C; Wollenberg A; Homey B
Eur J Med Res; 2012 Feb; 17(1):4. PubMed ID: 22472354
[TBL] [Abstract][Full Text] [Related]
36. Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial.
Gaiser MR; Lorenzen S; Merx K; Trojan J; Ocvirk J; Ettrich TJ; Al-Batran SE; Schulz H; Homann N; Feustel HP; Schatz M; Kripp M; Schulte N; Heeger S; Vlassak S; Koch W; Hofheinz RD
Ann Oncol; 2018 Dec; 29(12):2393-2395. PubMed ID: 30307464
[No Abstract] [Full Text] [Related]
37. [Contribution to acneiform eruptions by epidermal growth factor receptor inhibitors].
Bodet D; Bartralot R; Mollet J; Heras C; García-Patos V
Actas Dermosifiliogr; 2006 Mar; 97(2):148-9. PubMed ID: 16595122
[No Abstract] [Full Text] [Related]
38. Severe acneiform rash.
Yamamoto DS; Viale PH; Zhao G
Clin J Oncol Nurs; 2004 Dec; 8(6):654-6. PubMed ID: 15637959
[No Abstract] [Full Text] [Related]
39. [Acute acneform eruption secondary to cetuximab with good response to metronidazole].
Jiménez-Puya R; Gómez-García F; Rodríguez-Bujaldón A; Moreno-Giménez JC
Actas Dermosifiliogr; 2007 Nov; 98(9):648-9. PubMed ID: 17961460
[No Abstract] [Full Text] [Related]
40. Successful treatment with oral isotretinoin of acneiform skin lesions associated with cetuximab therapy.
Gutzmer R; Werfel T; Mao R; Kapp A; Elsner J
Br J Dermatol; 2005 Oct; 153(4):849-51. PubMed ID: 16181478
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
